HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01)].

Abstract
We carried out a survey of supportive care at institutions that participated in the JBCRG01 study (FEC followed by docetaxel) as neoadjuvant therapy for operable breast cancer. The purpose was to share the information of supportive care for the treatment effect of perioperative intensive chemotherapy among institutions. Appropriate supportive care for nausea, vomiting, edema and febrile neutropenia (FN) is important with respect to the safety of chemotherapy. According to the results of the questionnaire, support from the family and the relationships with doctors, nurses and pharmacists familiar with the chemotherapy were important. The equipment and service for outpatients' cancer chemotherapy center are also important. This multicenter study enhances the exchange of information among institutes. The results of this survey suggest that adequate supportive care makes anthracycline and taxane chemotherapy manageable in the outpatient setting.
AuthorsNorikazu Masuda, Masakazu Toi, Yuichi Takatsuka, Seigo Nakamura, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Mikihiro Kusama, Kazufumi Hisamatsu, Kosuke Yamazaki, Shin Eisei, Yasuyuki Sato, Hiroshi Kaise, Masahiro Kashiwaba, Hirotaka Iwase, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Japan Breast Cancer Research Group
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 34 Issue 10 Pg. 1609-15 (Oct 2007) ISSN: 0385-0684 [Print] Japan
PMID17940375 (Publication Type: English Abstract, Journal Article)
Topics
  • Breast Neoplasms (drug therapy)
  • Chemotherapy, Adjuvant (adverse effects)
  • Data Collection
  • Female
  • Humans
  • Neoadjuvant Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: